Acute altitude-induced hypoxia suppresses plasma glucose and leptin in healthy humans.
To examine the effects of acute altitude-induced hypoxia on the hormonal and metabolic response to ingested glucose, 8 young, healthy subjects (5 men and 3 women; age, 26 +/- 2 years; body mass index, 23.1 +/- 1.0 kg/m(2)) performed 2 randomized trials in a hypobaric chamber where a 75-g glucose solution was ingested under simulated altitude (ALT, 4300 m) or ambient (AMB, 362 m) conditions. Plasma glucose, insulin, C-peptide, epinephrine, leptin, and lactate concentrations were measured at baseline and 30, 60, 90, and 120 minutes after glucose ingestion during both trials. Compared with AMB, the plasma glucose response to glucose ingestion was reduced during the ALT trial (P = .04). There were no differences in the insulin and C-peptide responses between trials or in insulin sensitivity based on the homeostasis model assessment of insulin resistance. Epinephrine and lactate were both elevated during the ALT trial (P < .05), whereas the plasma leptin response was reduced compared with AMB (P < .05). The data suggest that the plasma glucose response is suppressed at ALT, but this is not due to insulin per se because insulin and C-peptide levels were similar for both trials. Elevated plasma epinephrine and lactate during ALT are indicative of increased glycogenolysis, which may have masked the magnitude of the reduced glucose response. We conclude that, during acute altitude exposure, there is a rapid metabolic response that is accompanied by a shift in the hormonal milieu that appears to favor increased glucose utilization.
Kelly
Karen R
KR
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Williamson
David L
DL
Fealy
Ciarán E
CE
Kriz
David A
DA
Krishnan
Raj K
RK
Huang
Hazel
H
Ahn
Janice
J
Loomis
Joseph L
JL
Kirwan
John P
JP
D000328:Adult; D000531:Altitude; D001786:Blood Glucose / Q000032:analysis*; D002096:C-Peptide / Q000097:blood; D004837:Epinephrine / Q000097:blood; D005260:Female; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D000860:Hypoxia / Q000097:blood* / Q000209:etiology*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D019344:Lactic Acid / Q000097:blood; D020738:Leptin / Q000097:blood*; D008297:Male; D012996:Solutions
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D020738:Leptin; D012996:Solutions; D019344:Lactic Acid; D005947:Glucose; D004837:Epinephrine